Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 020269

Expand all

DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% (DOBUTAMINE HYDROCHLORIDE)
EQ 50MG BASE/100ML
Marketing Status: Discontinued
Active Ingredient: DOBUTAMINE HYDROCHLORIDE
Proprietary Name: DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5%
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 50MG BASE/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N020269
Product Number: 001
Approval Date: Oct 19, 1993
Applicant Holder Full Name: HOSPIRA INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% (DOBUTAMINE HYDROCHLORIDE)
EQ 100MG BASE/100ML
Marketing Status: Discontinued
Active Ingredient: DOBUTAMINE HYDROCHLORIDE
Proprietary Name: DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5%
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 100MG BASE/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N020269
Product Number: 002
Approval Date: Oct 19, 1993
Applicant Holder Full Name: HOSPIRA INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% (DOBUTAMINE HYDROCHLORIDE)
EQ 200MG BASE/100ML
Marketing Status: Discontinued
Active Ingredient: DOBUTAMINE HYDROCHLORIDE
Proprietary Name: DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5%
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 200MG BASE/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N020269
Product Number: 003
Approval Date: Oct 19, 1993
Applicant Holder Full Name: HOSPIRA INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English